A PYMNTS Company

Spain’s Competition Regulator Fines Merck

By  |  October 25, 2022

Spain’s competition watchdog has slapped a 39 million-euro ($38.45 million) fine on US-based Merck for anti-competitive behaviour in a case brought by Spanish rival Insud Pharma over a contraception device.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The CNMC antitrust agency said in a statement on Tuesday Merck’s local unit, which had a monopoly on vaginal contraceptive rings in Spain between 2002 and 2018 with its Nuvaring device, prevented Insud Pharma in 2017 from marketing its own device through deceptive practices.

    Read more: Merck In $40B Deal For Cancer Biotech SeaGen

    Merck Sharp & Dohme (MSD), the official name of Merck & Co outside the United States and Canada obtained a court order barring Insud Pharma from manufacturing the devices in Spain, where it has all its operations, hence preventing sales all over the world, the CNMC said.

    “MSD deployed a strategy of deception with the court, hiding relevant factual and technical information,” it said, calling it a very serious infringement that constituted an abuse of dominant position.